• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种高通量 CRISPR 干扰筛选技术,用于解析 GPCR/cAMP 信号转导功能调控因子。

A high-throughput CRISPR interference screen for dissecting functional regulators of GPCR/cAMP signaling.

机构信息

Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, United States of America.

Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America.

出版信息

PLoS Genet. 2020 Oct 14;16(10):e1009103. doi: 10.1371/journal.pgen.1009103. eCollection 2020 Oct.

DOI:10.1371/journal.pgen.1009103
PMID:33052901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7588078/
Abstract

G protein-coupled receptors (GPCRs) allow cells to respond to chemical and sensory stimuli through generation of second messengers, such as cyclic AMP (cAMP), which in turn mediate a myriad of processes, including cell survival, proliferation, and differentiation. In order to gain deeper insights into the complex biology and physiology of these key cellular pathways, it is critical to be able to globally map the molecular factors that shape cascade function. Yet, to this date, efforts to systematically identify regulators of GPCR/cAMP signaling have been lacking. Here, we combined genome-wide screening based on CRISPR interference with a novel sortable transcriptional reporter that provides robust readout for cAMP signaling, and carried out a functional screen for regulators of the pathway. Due to the sortable nature of the platform, we were able to assay regulators with strong and moderate phenotypes by analyzing sgRNA distribution among three fractions with distinct reporter expression. We identified 45 regulators with strong and 50 regulators with moderate phenotypes not previously known to be involved in cAMP signaling. In follow-up experiments, we validated the functional effects of seven newly discovered mediators (NUP93, PRIM1, RUVBL1, PKMYT1, TP53, SF3A2, and HRAS), and showed that they control distinct steps of the pathway. Thus, our study provides proof of principle that the screening platform can be applied successfully to identify bona fide regulators of GPCR/second messenger cascades in an unbiased and high-throughput manner, and illuminates the remarkable functional diversity among GPCR regulators.

摘要

G 蛋白偶联受体(GPCRs)通过生成第二信使(如环腺苷酸[cAMP])使细胞能够对化学和感官刺激做出反应,而 cAMP 又介导了包括细胞存活、增殖和分化在内的多种过程。为了更深入地了解这些关键细胞途径的复杂生物学和生理学,能够全局绘制塑造级联功能的分子因素至关重要。然而,迄今为止,系统性鉴定 GPCR/cAMP 信号转导调节剂的努力一直缺乏。在这里,我们将基于 CRISPR 干扰的全基因组筛选与一种新型可分选转录报告基因相结合,该报告基因可提供 cAMP 信号的强大读数,并对该途径的调节剂进行功能筛选。由于该平台具有可分选的性质,我们能够通过分析三个具有不同报告基因表达的分数中的 sgRNA 分布来检测具有强表型和中表型的调节剂。我们鉴定出 45 个强表型调节剂和 50 个以前不参与 cAMP 信号转导的中表型调节剂。在后续实验中,我们验证了七个新发现的介质(NUP93、PRIM1、RUVBL1、PKMYT1、TP53、SF3A2 和 HRAS)的功能效应,并表明它们控制了该途径的不同步骤。因此,我们的研究证明了筛选平台可以成功地应用于以无偏和高通量的方式识别 GPCR/第二信使级联的真正调节剂,并阐明了 GPCR 调节剂之间显著的功能多样性。

相似文献

1
A high-throughput CRISPR interference screen for dissecting functional regulators of GPCR/cAMP signaling.一种高通量 CRISPR 干扰筛选技术,用于解析 GPCR/cAMP 信号转导功能调控因子。
PLoS Genet. 2020 Oct 14;16(10):e1009103. doi: 10.1371/journal.pgen.1009103. eCollection 2020 Oct.
2
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.全基因组CRISPR-Cas9筛选揭示胶质母细胞瘤干细胞中PKMYT1和WEE1之间冗余性的丧失。
Cell Rep. 2015 Dec 22;13(11):2425-2439. doi: 10.1016/j.celrep.2015.11.021. Epub 2015 Dec 7.
3
DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery.DCyFIR:一种高通量 CRISPR 平台,用于多重 G 蛋白偶联受体分析和配体发现。
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):13117-13126. doi: 10.1073/pnas.2000430117. Epub 2020 May 20.
4
Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.通过全激酶组 CRISPR-Cas9 文库对骨肉瘤进行潜在治疗靶点的系统筛选。
Cancer Biol Med. 2020 Aug 15;17(3):782-794. doi: 10.20892/j.issn.2095-3941.2020.0162.
5
RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.RUVBL1 是一种扩增的表观遗传因子,可促进头颈部鳞状细胞癌的增殖并抑制分化程序。
Oral Oncol. 2020 Dec;111:104930. doi: 10.1016/j.oraloncology.2020.104930. Epub 2020 Jul 31.
6
Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.基因网络推断和生化评估描绘了小肠类器官神经内分泌肿瘤中的 GPCR 通路和 CREB 靶标。
PLoS One. 2011;6(8):e22457. doi: 10.1371/journal.pone.0022457. Epub 2011 Aug 11.
7
Members of the KCTD family are major regulators of cAMP signaling.KCTD 家族成员是 cAMP 信号的主要调节因子。
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1). doi: 10.1073/pnas.2119237119.
8
The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction.精神病风险因素 RBM12 编码一种新型的 GPCR/cAMP 信号转导抑制剂。
J Biol Chem. 2023 Sep;299(9):105133. doi: 10.1016/j.jbc.2023.105133. Epub 2023 Aug 4.
9
Systematic Quantification of GPCR/cAMP-Controlled Protein Kinase A Interactions.G蛋白偶联受体/cAMP调控的蛋白激酶A相互作用的系统定量分析
Horm Metab Res. 2017 Apr;49(4):240-249. doi: 10.1055/s-0042-110791. Epub 2016 Aug 2.
10
LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.长链非编码 RNA PKMYT1AR 通过激活 Wnt 信号通路促进非小细胞肺癌中的癌症干细胞维持。
Mol Cancer. 2021 Dec 2;20(1):156. doi: 10.1186/s12943-021-01469-6.

引用本文的文献

1
Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation.工程化新型CRISPRi阻遏物用于高效的哺乳动物基因调控。
Genome Biol. 2025 Jun 12;26(1):164. doi: 10.1186/s13059-025-03640-4.
2
Chemical biology approaches to resolve the subcellular GPCR signaling landscape.用于解析亚细胞GPCR信号转导格局的化学生物学方法。
Nat Chem Biol. 2025 Jun 2. doi: 10.1038/s41589-025-01928-x.
3
dFLASH; dual FLuorescent transcription factor activity sensor for histone integrated live-cell reporting and high-content screening.

本文引用的文献

1
CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma.基于 CRISPR 的筛选揭示了多发性骨髓瘤免疫治疗反应的决定因素。
Blood Adv. 2020 Jul 14;4(13):2899-2911. doi: 10.1182/bloodadvances.2019001346.
2
G protein-regulated endocytic trafficking of adenylyl cyclase type 9.G 蛋白调节的腺苷酸环化酶 9 的内吞运输。
Elife. 2020 Jun 9;9:e58039. doi: 10.7554/eLife.58039.
3
Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation.ESCRT 途径功能受损促进 tau 种子的内溶酶体逃逸和 tau 聚集的传播。
dFLASH;用于组蛋白整合活细胞报告和高内涵筛选的双荧光转录因子活性传感器。
Nat Commun. 2025 Apr 7;16(1):3298. doi: 10.1038/s41467-025-58488-w.
4
Extensive location bias of the GPCR-dependent translatome via site-selective activation of mTOR.通过mTOR的位点选择性激活实现GPCR依赖性翻译组的广泛定位偏差
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2414738122. doi: 10.1073/pnas.2414738122. Epub 2025 Feb 18.
5
Genome-wide pan-GPCR cell libraries accelerate drug discovery.全基因组泛G蛋白偶联受体细胞文库加速药物发现。
Acta Pharm Sin B. 2024 Oct;14(10):4296-4311. doi: 10.1016/j.apsb.2024.06.023. Epub 2024 Jun 26.
6
An engineered trafficking biosensor reveals a role for DNAJC13 in DOR downregulation.一种工程化的转运生物传感器揭示了DNAJC13在DOR下调中的作用。
Nat Chem Biol. 2025 Mar;21(3):360-370. doi: 10.1038/s41589-024-01705-2. Epub 2024 Sep 2.
7
Extensive location bias of the GPCR-dependent translatome via site-selective activation of mTOR.通过mTOR的位点选择性激活实现GPCR依赖性翻译组的广泛定位偏差。
bioRxiv. 2024 Jun 18:2024.06.17.599400. doi: 10.1101/2024.06.17.599400.
8
Quantitative proteomics reveals CLR interactome in primary human cells.定量蛋白质组学揭示了原代人细胞中的 CLR 相互作用组。
J Biol Chem. 2024 Jun;300(6):107399. doi: 10.1016/j.jbc.2024.107399. Epub 2024 May 20.
9
CRISPR applications in cancer diagnosis and treatment.CRISPR 在癌症诊断与治疗中的应用。
Cell Mol Biol Lett. 2023 Sep 6;28(1):73. doi: 10.1186/s11658-023-00483-4.
10
Endosome positioning coordinates spatially selective GPCR signaling.内体定位协调空间选择性 GPCR 信号转导。
Nat Chem Biol. 2024 Feb;20(2):151-161. doi: 10.1038/s41589-023-01390-7. Epub 2023 Jul 27.
J Biol Chem. 2019 Dec 13;294(50):18952-18966. doi: 10.1074/jbc.RA119.009432. Epub 2019 Oct 2.
4
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.基于 CRISPR 干扰的平台,用于在人类 iPSC 衍生神经元中进行多模式遗传筛选。
Neuron. 2019 Oct 23;104(2):239-255.e12. doi: 10.1016/j.neuron.2019.07.014. Epub 2019 Aug 15.
5
The Gene Ontology Resource: 20 years and still GOing strong.《基因本体论资源:20 年,持续强大》
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338. doi: 10.1093/nar/gky1055.
6
Mapping the Genetic Landscape of Human Cells.绘制人类细胞的遗传全景图。
Cell. 2018 Aug 9;174(4):953-967.e22. doi: 10.1016/j.cell.2018.06.010. Epub 2018 Jul 19.
7
Application of CRISPR-Cas9 Based Genome-Wide Screening Approaches to Study Cellular Signalling Mechanisms.基于 CRISPR-Cas9 的全基因组筛选方法在研究细胞信号转导机制中的应用。
Int J Mol Sci. 2018 Mar 21;19(4):933. doi: 10.3390/ijms19040933.
8
Trends in GPCR drug discovery: new agents, targets and indications.G蛋白偶联受体(GPCR)药物研发趋势:新药物、靶点与适应症
Nat Rev Drug Discov. 2017 Dec;16(12):829-842. doi: 10.1038/nrd.2017.178. Epub 2017 Oct 27.
9
Selection and identification of transferrin receptor-specific peptides as recognition probes for cancer cells.转铁蛋白受体特异性肽的筛选和鉴定作为癌细胞的识别探针。
Anal Bioanal Chem. 2018 Jan;410(3):1071-1077. doi: 10.1007/s00216-017-0664-4. Epub 2017 Oct 18.
10
CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.CRISPRi 和 CRISPRa 哺乳动物细胞筛选技术在精准生物学和医学中的应用
ACS Chem Biol. 2018 Feb 16;13(2):406-416. doi: 10.1021/acschembio.7b00657. Epub 2017 Oct 24.